Regenerative nanomedicine and the treatment of degenerative retinal diseases
Version of Record online: 14 DEC 2011
Copyright © 2011 Wiley Periodicals, Inc.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Volume 4, Issue 1, pages 113–137, January/February 2012
How to Cite
Zarbin, M. A., Montemagno, C., Leary, J. F. and Ritch, R. (2012), Regenerative nanomedicine and the treatment of degenerative retinal diseases. WIREs Nanomed Nanobiotechnol, 4: 113–137. doi: 10.1002/wnan.167
- Issue online: 14 DEC 2011
- Version of Record online: 14 DEC 2011
Regenerative medicine deals with the repair or the replacement of tissues and organs using advanced materials and methodologies. Regenerative nanomedicine uses nanoparticles containing gene transcription factors and other modulating molecules that allow reprogramming of cells in vivo as well as nanomaterials to induce selective differentiation of neural progenitor cells and to create neural-mechanical interfaces. In this article, we consider some applications of nanotechnology that may be useful for the treatment of degenerative retinal diseases, for example, use of nanoparticles for drug and gene therapy, use of nanomaterials for neural interfaces and extracellular matrix construction for cell-based therapy and neural prosthetics, and the use of bionanotechnology to re-engineer proteins and cell behavior for regenerative medicine. WIREs Nanomed Nanobiotechnol 2012, 4:113–137. doi: 10.1002/wnan.167
For further resources related to this article, please visit the WIREs website.